AdvaMed CEO Panel: Medtech Needs ‘Leapfrog-Type Improvements’

What should the medical device industry do now, as it faces a perfect storm of a tight funding climate, price pressures, a tough regulatory environment, as well as the new medical device tax? “It has probably never been harder to bring a device from the bench to the bedside,” reflected Stephen Ubl, AdvaMed president and CEO, who served as a moderator for the AdvaMed CEOs Unplugged Panel.
MDDI